Abstract:Skin
interstitial fluid (ISF) is a biofluid with information-rich
biomarkers for disease diagnosis and prognosis. Microneedle (MN) integration
of sampling and instant biomarker readout hold great potential in
health status monitoring and point-of-care testing (POCT). The present
work describes an attractive MN sensor array for minimally invasive
monitoring of ISF microRNA (miRNA) and Cu2+. The MN array
is made of methacrylated gelatin (GelMA) and methacrylated hyaluronic
acid (MeHA), and a further divisionally… Show more
“…So far, targets of integrated microneedle-integrated detection systems have covered ions, 50,118 small molecules (glucose, 119–122,124 lactate, 30,123 cholesterol 125 and ROS 126,127 ), and nucleic acids. 49,100,116,128,129 In this section, we summarize recently reported integrated microneedle sensing devices, highlighting distinct sensing principles including colorimetric, fluorometric and electronic systems (Fig. 1).…”
This review summarizes state-of-the-art microneedle-based detection and sensing systems, highlighting the objective significance, sensing principles, systematic construction, and validation models of these microneedles.
“…So far, targets of integrated microneedle-integrated detection systems have covered ions, 50,118 small molecules (glucose, 119–122,124 lactate, 30,123 cholesterol 125 and ROS 126,127 ), and nucleic acids. 49,100,116,128,129 In this section, we summarize recently reported integrated microneedle sensing devices, highlighting distinct sensing principles including colorimetric, fluorometric and electronic systems (Fig. 1).…”
This review summarizes state-of-the-art microneedle-based detection and sensing systems, highlighting the objective significance, sensing principles, systematic construction, and validation models of these microneedles.
“…MNP technology is a new device with high drug delivery efficiency, easy administration, painless, low risk of infection, and has strong potential for clinical application, which is expected to become an effective drug delivery route for an insulin treatment of diabetes (Li et al., 2022 ). HA MNP has become an excellent choice for diabetes treatment because it facilitates wound healing, including micropores from injections and chronic wounds from diabetes.…”
Section: Applications Of Ha Mnp As An Excellent Drug Carriermentioning
confidence: 99%
“…The natural water absorption of HA makes it an ideal candidate for rapid ISF extraction. Extraction of ISF with HA MNP is becoming an emerging method for the diagnosis and prognosis of diseases (Li et al., 2022 ).…”
Section: Applications Of Ha Mnp As An Excellent Drug Carriermentioning
Microneedle patch (MNP) is an alternative to the oral route and subcutaneous injection with unique advantages such as painless administration, good compliance, and fewer side effects. Herein, we report MNP as a prominent strategy for drug delivery to treat local or systemic disease. Hyaluronic acid (HA) has advantageous properties, such as human autologous source, strong water absorption, biocompatibility, and viscoelasticity. Therefore, the Hyaluronic acid microneedle patch (HA MNP) occupies a large part of the MNP market. HA MNP is beneficial for wound healing, targeted therapy of certain specific diseases, extraction of interstitial skin fluid (ISF), and preservation of drugs. In this review, we summarize the benefits of HA and cross-linked HA (x-HA) as an MNP matrix. Then, we introduce the types of HA MNP, delivered substances, and drug distribution. Finally, we focus on the biomedical application of HA MNP as an excellent drug carrier in some specific diseases and the extraction and analysis of biomarkers. We also discuss the future development prospect of HA MNP in transdermal drug delivery systems (TDDS).
“…2 Therefore, the composition similarity of ISF to blood enables ISF to be a promising candidate for point-of-care testing (POCT) diagnosis. 4,5 Microneedles (MNs) are known as powerful tools to pass through the skin epidermis to reach the dermis, where MNs can make contact with ISF for collecting and detecting analytes. 6−8 The small tip size (1−100 μm) and appropriate needle length (50−2000 μm) without touching the nerve enable MNs minimally invasive and painless puncture.…”
mentioning
confidence: 99%
“…For proteins with a higher molecular weight, the concentration ratio between the ISF and blood has been investigated to vary in an inverse logarithmic relationship . Therefore, the composition similarity of ISF to blood enables ISF to be a promising candidate for point-of-care testing (POCT) diagnosis. , …”
Microneedles (MNs) are currently one of the most promising tools for skin interstitial fluid (ISF)-based biosensing, while it is still a challenge to expand the detectable biomarkers in ISF due to limited MNs types and detection techniques. Herein, highly sensitive internal-standard surface-enhanced Raman scattering microneedles (IS-SERS-MNs) were developed, which enabled the reliable detection of bacterial metabolites in ISF as new detectable biomarkers for infection diagnosis. The developed IS-SERS-MNs can not only directly detect pyocyanin (a representative bacterial metabolite) present in mouse dermal ISF but also indirectly detect pyocyanin in the hypodermis via its diffusion into the dermis, revealing a new possible pathway for the source of biomarkers in dermal ISF. Moreover, the SERS signal of pyocyanin was also clearly detected at real mouse wounds, indicating that the developed IS-SERS-MNs have great potential in minimally invasive and painless diagnosis of bacterial infection via a new ISF route. This work not only develops IS-SERS-MNs as a powerful tool for expanding the application of SERS-based MNs but also provides a new chance for ISF-related infection diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.